Cargando…

Aberrant cytokeratin 7 expression by hepatocytes can predict the ductopenia grade in primary biliary cholangitis

BACKGROUND: Aberrant cytokeratin 7 expression by hepatocytes (CK7(+)Hs) is the hallmark characteristic of cholestasis diseases, especially in ductopenia diseases such as primary biliary cholangitis (PBC). This study attempted to evaluate the differences and relationships between the clinical and his...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hong-Li, Yang, An-Yin, Xiong, Qing-Fang, Zhong, Yan-Dan, Liu, Du-Xian, Huang, Ping, Feng, Xiao-Ning, Zhang, Yu, Yang, Yong-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628093/
https://www.ncbi.nlm.nih.gov/pubmed/36324070
http://dx.doi.org/10.1186/s12876-022-02538-w
Descripción
Sumario:BACKGROUND: Aberrant cytokeratin 7 expression by hepatocytes (CK7(+)Hs) is the hallmark characteristic of cholestasis diseases, especially in ductopenia diseases such as primary biliary cholangitis (PBC). This study attempted to evaluate the differences and relationships between the clinical and histological features of aberrant cytokeratin 7 (CK7) expression by hepatocytes in PBC patients. METHODS: The clinicopathological data of patients diagnosed with PBC at the Second Hospital of Nanjing between January 2016 and September 2018 were analysed with SPSS 20.0. RESULTS: Eighty-nine PBC patients who underwent liver biopsy were enrolled in this study, and 15, 29 and 45 patients had aberrant CK7 expression by hepatocytes (CK7(+)Hs (2 +), CK7(+)Hs (1 +), and CK7(−)Hs, respectively). There were significant differences in TB, DB, ALP, TA, IgM, interface activity, and ductopenia grade between patients with CK7(−)Hs and CK7(+)Hs (2 +) (P < 0.05). The ductopenia grade was also significantly different between patients with CK7(+)Hs (2 +) and CK7(+)Hs (1 +) according to sex (P < 0.05). Upon merging the data of CK7(+)Hs (2 +) and CK7(+)Hs (1 +) into CK7(+)Hs, we found significant differences in AMA, AMA-M2, anti-gp210, TB, DB, ALP, TA, IgM, fibrosis, and ductopenia grade between CK7(+)Hs and CK7(−)Hs (P < 0.05). The odds ratios (ORs) (and 95% confidence intervals (CIs)) of CK7(+)Hs according to anti-gp210, ductopenia grade, and interface activity were 6.413 (95% CI 1.363–30.162), 4.145 (95% CI 1.898–9.052) and 3.247 (95% CI 1.556–6.775), respectively (P < 0.05). Spearman's rank correlation according to interface activity and ductopenia grade in patients with CK7(+)Hs (2 + , 1 + , 0) was r = 0.359 (P = 0.001) and r = 0.396 (P < 0.001), respectively. CONCLUSION: CK7(+)Hs serves as a cholestasis index of PBC and are associated with the ductopenia grade and interface activity. Aberrant cytokeratin 7 expression by hepatocytes can predict the ductopenia grade in primary biliary cholangitis.